Latest News about MRK
Recent news which mentions MRK
Skipping Eye Exams Linked to Nearly 6 Million Cases of Preventable Vision Loss, According to Vision Care Experts
November 19, 2021
From Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting
November 18, 2021
Tickers
MRK
From Benzinga
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
From Benzinga
From Motley Fool
From Benzinga
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
From Motley Fool
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
November 17, 2021
From Motley Fool
Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters
November 16, 2021
From Benzinga
Here’s why tech could be the sweet spot for next year, but this hot sector is a no, says Wells Fargo
November 16, 2021
From MarketWatch
Merck Is a Dividend Play Ready to Get Back in Gear
November 16, 2021
From InvestorPlace
From Benzinga
Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment
November 14, 2021
Tickers
MRK
From MarketWatch
Better Buy: Bristol Myers Squibb vs. Merck
November 13, 2021
From Motley Fool
Pfizer: Bull vs. Bear
November 13, 2021
From Motley Fool
Is Merck's Planned Acquisition of Acceleron in Trouble?
November 12, 2021
From Motley Fool
Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement
November 11, 2021
From Benzinga
This Company Says It's One Step Closer to Transforming Cancer Treatment with its Latest Groundbreaking Immunotherapy
November 11, 2021
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
From InvestorPlace
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Could Pfizer's COVID Pill Be Even Bigger Than Its Vaccine?
November 10, 2021
From Motley Fool
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
From Benzinga
Pfizer and BioNTech to seek backing for COVID-19 booster in all U.S. adults aged 18 and over, as deaths still average 1,200 a day
November 09, 2021
From MarketWatch
US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill
November 09, 2021
Tickers
MRK
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
Better COVID Stock: Merck vs. Pfizer
November 09, 2021
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.